Pfizer's addition of a new vaccine suite and multiproduct bioprocess suite to its Ireland facility win the company the title of 2014 Facility of the Year.
The International Society for Pharmaceutical Engineers (ISPE) recognized Pfizer Ireland as the overall winner in the 2014 Facility of the Year Awards (FOYA) category at the society’s annual meeting in Las Vegas, Nevada. FOYA acknowledges the pharmaceutical manufacturing industry’s accomplishments in construction and facility design and the pursuit of new technologies.
The focus of Pfizer Ireland’s Network Strategy Implementation (NSI) Capacity project was the addition of a new vaccine suite and a drug substance bioprocess suite. The new manufacturing suites included the latest technologies, including electronic batch records, process analytical technology, and disposable bag processing. Pfizer Ireland conducted the project using a lean management strategy, a 5S program in the design process, and a Six Sigma toolkit. The Pfizer Ireland Grange Castle plant that won the award is located in Clondalkin, South County Dublin.
“The society was impressed with the NSI Capacity Expansion project and the company’s ability to effectively manage the challenges of maintaining supply with the demolition of existing facilities, new construction, and start-up and integration activities,” said Chair of the FOYA Judging Panel James Breen in a press release.
SOURCE: ISPE
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.